254 related articles for article (PubMed ID: 30582389)
1. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
Satish M; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
[TBL] [Abstract][Full Text] [Related]
3. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
[TBL] [Abstract][Full Text] [Related]
4. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
5. Specialized pro-resolving mediators in cardiovascular diseases.
Fredman G; Spite M
Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
7. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy.
Kim AS; Conte MS
Adv Drug Deliv Rev; 2020; 159():170-179. PubMed ID: 32697951
[TBL] [Abstract][Full Text] [Related]
8. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
[TBL] [Abstract][Full Text] [Related]
9. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
[TBL] [Abstract][Full Text] [Related]
10. The role of non-resolving inflammation in atherosclerosis.
Kasikara C; Doran AC; Cai B; Tabas I
J Clin Invest; 2018 Jul; 128(7):2713-2723. PubMed ID: 30108191
[TBL] [Abstract][Full Text] [Related]
11. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.
Wu B; Mottola G; Schaller M; Upchurch GR; Conte MS
Mol Aspects Med; 2017 Dec; 58():72-82. PubMed ID: 28765077
[TBL] [Abstract][Full Text] [Related]
12. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases.
Shang P; Zhang Y; Ma D; Hao Y; Wang X; Xin M; Zhang Y; Zhu M; Feng J
Expert Opin Ther Targets; 2019 Nov; 23(11):967-986. PubMed ID: 31711309
[No Abstract] [Full Text] [Related]
13. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
Spite M; Fredman G
Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
[TBL] [Abstract][Full Text] [Related]
14. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
Chatterjee A; Komshian S; Sansbury BE; Wu B; Mottola G; Chen M; Spite M; Conte MS
FASEB J; 2017 Aug; 31(8):3393-3402. PubMed ID: 28442547
[TBL] [Abstract][Full Text] [Related]
16. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
Serhan CN; de la Rosa X; Jouvene C
J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
[TBL] [Abstract][Full Text] [Related]
17. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuning inflammation-resolution programs: focus on atherosclerosis.
Fredman G; Sadhu S; Rymut N
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):117-123. PubMed ID: 27984234
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
Fredman G; MacNamara KC
Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
[TBL] [Abstract][Full Text] [Related]
20. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
Recchiuti A; Serhan CN
Front Immunol; 2012; 3():298. PubMed ID: 23093949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
